Luye Pharma Group Limited — Earnings Release 2001

Jul 24, 2001

Listed Company Information

TAKSON HOLDINGS<0918> - Results Announcement (Summary) Takson Holdings Limited announced on 24/7/2001: (stock code: 918) Year end date: 31/3/2001 Currency: HK$ (Audited) (Audited) Last Current Corresponding Period Period from 1/4/2000 from 1/4/1999 to 31/3/2001 to 31/3/2000 ('000) ('000) Turnover : 514,357 480,713 Profit/(Loss) from Operations : (54,692) 68,966 Finance cost : (13,561) (8,061) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : (1,321) (195) Profit/(Loss) after Tax & MI : (69,836) 50,425 % Change over Last Period : N/A EPS/(LPS)-Basic : (18.2 cents) 13.9 cents -Diluted : N/A 13.0 cents Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (69,836) 50,425 Final Dividend per Share : NIL 11.0 cents (Specify if with other options) : N/A N/A B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : N/A B/C Dates for Other Distribution : N/A Remarks: (1) (Loss)/profit from operations (Loss)/profit from operations is stated after charging the following: 2001 2000 HK$000 HK$000 Impairment loss on leasehold land and buildings (35,620) - Provision for loss on down materials (16,588) - Provision for loss on textile quota (18,756) - =========================== (2) (Loss)/earnings per share The calculation of basic and diluted (loss)/earnings per share is based on the Group's loss attributable to shareholders of HK$69,836,000 (2000: profit of HK$50,425,000). The basic (loss)/earnings per share is based on the weighted average number of 384,743,014 (2000: 363,529,372) ordinary shares in issue during the year. Diluted loss per share for the year ended 31st March 2001, is not shown as there is no dilution arising from the outstanding share options in issue during the year ended 31st March, 2001. The diluted earnings per share for the year ended 31st March, 2000 is based on 363,529,372 ordinary shares which is the weighted average number of ordinary shares in issue during the year plus the weighted average number of 23,988,032 ordinary shares deemed to be issued at no consideration if all outstanding options had been exercised. (3) Comparative figures Certain comparative figures have been reclassified to conform with the current year's presentation.